Cargando…

Canadian Real‐World Outcomes of Omnipod Initiation in People with Type 1 Diabetes (COPPER study): Evidence from the LMC Diabetes Registry

AIMS: To investigate real‐world clinical outcomes in adults with type 1 diabetes who initiated the Omnipod Insulin Management System (Insulet Corp., Acton, MA, USA) compared to a matched cohort who maintained multiple daily injection therapy. METHODS: This retrospective observational study used data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, R. E., Vienneau, T., Aronson, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research: Treatment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246772/ https://www.ncbi.nlm.nih.gov/pubmed/33040383 http://dx.doi.org/10.1111/dme.14420

Ejemplares similares

Semaglutide once weekly in people with type 2 diabetes: Real‐world analysis of the Canadian LMC diabetes registry (SPARE study)
por: Brown, Ruth E, et al.
Publicado: (2020)

Real‐world glycaemic outcomes in adult persons with type 1 diabetes using a real‐time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL‐CGM‐T1D)
por: Brown, Ruth E., et al.
Publicado: (2022)

The LMC Skills, Confidence & Preparedness Index (SCPI): development and evaluation of a novel tool for assessing self-management in patients with diabetes
por: Mbuagbaw, Lawrence, et al.
Publicado: (2017)

Clinical Implementation of the Omnipod 5 Automated Insulin Delivery System: Key Considerations for Training and Onboarding People With Diabetes
por: Berget, Cari, et al.
Publicado: (2022)

Reliability and validity of the Chinese version of the LMC Skills, Confidence & Preparedness Index (SCPI) in patients with type 2 diabetes
por: Wang, Ximin, et al.
Publicado: (2021)

An x-ray image of the LMC
Publicado: (1994)

Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy
por: Davis, Georgia M., et al.
Publicado: (2023)

The Use of Omnipod® 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes With Suboptimal Glycemic Management: From Injections to Closed-Loop Therapy
por: Bode, Bruce W, et al.
Publicado: (2021)

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
por: Niitsu, Takayuki, et al.
Publicado: (2023)

Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data
por: Mease, Philip, et al.
Publicado: (2020)

Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting
por: Liang, Huifang, et al.
Publicado: (2019)

Budget impact analysis and treatment availability with biosimilar TNF inhibitors in rheumatic diseases in Poland: real-world evidence using a nationwide database
por: Stajszczyk, Marcin, et al.
Publicado: (2023)

An empirical model of Drosophila Photoreceptor-LMC network
por: Luna, Carlos, et al.
Publicado: (2015)

Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes
por: Buckingham, Bruce A., et al.
Publicado: (2018)

Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes
por: Forlenza, Gregory P., et al.
Publicado: (2019)

Why Do so Few People with Heart Failure Receive Cardiac Rehabilitation?
por: Thompson, David R, et al.
Publicado: (2022)

Swimming With the Omnipod 5 Automated Insulin Delivery System: Connectivity in the Water
por: Hughes, Michael S., et al.
Publicado: (2023)

The Alcohol Improvement Programme: Evaluation of an Initiative to Address Alcohol-Related Health Harm in England
por: Thom, Betsy, et al.
Publicado: (2013)

In-hospital Initiation and Up-titration of Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction
por: Cox, Zachary L, et al.
Publicado: (2022)

Non-pharmacological interventions to promote work participation in people with rheumatic and musculoskeletal diseases: a systematic review and meta-analysis from the EULAR taskforce on healthy and sustainable work participation
por: Butink, Maarten H P, et al.
Publicado: (2023)

The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction
por: Brownell, Nicholas K, et al.
Publicado: (2021)

Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk
por: Tardelli, Vitor, et al.
Publicado: (2023)

The OmniPod Insulin Management System: the latest innovation in insulin pump therapy
por: Zisser, Howard C.
Publicado: (2010)

Safety Evaluation of the Omnipod® 5 Automated Insulin Delivery System Over Three Months of Use in Children With Type 1 Diabetes (T1D)
por: Buckingham, Bruce A, et al.
Publicado: (2021)

Non-surgical and surgical treatments for rotator cuff disease: a pragmatic randomised clinical trial with 2-year follow-up after initial rehabilitation
por: Cederqvist, Sanna, et al.
Publicado: (2021)

Effect of Astragalus membranaceus extract on diabetic nephropathy
por: Kim, Jiman, et al.
Publicado: (2014)

AGAPEROS: Searches for microlensing in the LMC with the Pixel Method; 2, Selection of possible microlensing events
por: Melchior, A.L., et al.
Publicado: (1998)

Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention
por: DeFronzo, Ralph A., et al.
Publicado: (2011)

Multidrug Treatment of Type 2 Diabetes: A challenge for compliance
por: Miccoli, Roberto, et al.
Publicado: (2011)

Glucokinase Activators for Diabetes Therapy: May 2010 status report
por: Matschinsky, Franz M., et al.
Publicado: (2011)

Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes
por: Handelsman, Yehuda
Publicado: (2011)

Use of plasma rich in growth factors for symptoms of diabetic neuropathy
por: Roman, S J, et al.
Publicado: (2023)

The Book World of Medicine and Science
Publicado: (1907)

Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions
por: Sherr, Jennifer L., et al.
Publicado: (2020)

Pasireotide in an insulin-requiring diabetic acromegalic patient without worsening of hyperglycemia
por: Gordon, Murray B, et al.
Publicado: (2017)

Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes
por: Cahn, Avivit, et al.
Publicado: (2016)

The top 10 research priorities in diabetes and pregnancy according to women, support networks and healthcare professionals
por: Ayman, Göher, et al.
Publicado: (2021)

Use of acetazolamide in lithium-induced nephrogenic diabetes insipidus: a case report
por: Macau, Ricardo A, et al.
Publicado: (2018)

Successful long-term use of pioglitazone in Berardinelli–Seip lipodystrophy-associated diabetes
por: Chaves, Carolina, et al.
Publicado: (2021)

Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors
por: Pitt, Bertram, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5tff9vlhotav3s46sdit9e0bgj